Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on Axsome Therapeutics, Raises Price Target to $75

SVB Leerink analyst Marc Goodman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and raises the price target from $50 to $75.
byBenzinga Newsdesk
August 22, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Marc Goodman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and raises the price target from $50 to $75.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts